Stanford University and the U.S. energy department’s Stanford Linear Accelerator Center (SLAC) have combined forces to create the new SLAC-Stanford Battery Research Center. Its focus is on merging government investment and the technological savvy of Silicon Valley to invent “batteries and energy storage technologies with the goal of developing a sustainable path for electrifying key economic sectors, including transportation, the electric grid, industry, manufacturing and development.”
Cyborg cells—living bacteria infused with a polymer network created by scientists at the University of California Davis—can survive the body’s immune system and deliver a lethal chemical cocktail to cancer tumors, the researchers have shown.
No one’s built a working prototype yet, but engineers at Texas A&M University have used detailed computer calculations and initial experiments to show that water-based batteries are not only possible, but better than today’s workhorse lithium-ion power cells.
The brain cancer called glioblastoma has a 100-percent fatality rate. A person’s median survival time after being diagnosed is just 16 months.
Social media has long been a cesspit of breathless rumors, baseless conspiracy theories, and outright lies.
Coffee cup lids, the plastic film encasing paper towels, and the infinite number of single-use plastic shopping bags can be the source of energy and raw materials, if we only knew how to unlock their chemical bonds at a practical cost.
ExxonMobil may have shut down its algae-based fuel project, but no one else seems to be giving up on the idea of turning these stemless plants into industrial workhorses.
Imagine super soldiers who can shrug off a chemical weapons attack and keep right on waging war.
Engineers at the Vienna University of Technology have created a battery that needs no hard-to-come-by materials, uses no nickel or cobalt, can’t catch fire, and can be regenerated when the performance begins to degrade with time.
Immunotherapy is cancer treatment’s new go-to remedy. Technicians take white blood cells from a patient—the “killer T cells” of the immune system —isolate the ones best suited to fight the patient’s form of cancer, then genetically engineer them to be “super T cells” able to overcome cancer’s defenses.